How to interpret IGF-1 and growth hormone stimulation tests

被引：1

作者：

Tseretopoulou, Xanthippi ^{[1
]}

Mushtaq, Talat ^{[2
]}

机构：

[1] Addenbrookes Hosp, Paediat Endocrinol, Cambridge, England

[2] Leeds Teaching Hosp NHS Trust, Paediat Endocrinol, Leeds, W Yorkshire, England

来源：

ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION | 2020年 / 105卷 / 05期

关键词：

endocrinology; general paediatrics; growth; FACTOR-I; SHORT CHILDREN; DIAGNOSIS; BINDING; CHILDHOOD; ADOLESCENTS; DEFICIENCY;

D O I：

10.1136/archdischild-2019-318466

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

You are seeing an 11-year-old boy in a general paediatric clinic referred with short stature. His height is below the 0.4th centile. The mid-parental height is on 50th centile. Baseline investigations, including renal and liver function, coeliac screen and thyroid function tests are normal. You have a suspicion of growth hormone deficiency. Should you check an insulin-like growth factor-1 level or proceed with a growth hormone provocation test? The current paper will aim to give an overview of these tests and factors to consider when interpreting the results.

引用

页码：311 / 314

页数：4

共 50 条

[1] Diagnostic Value of IGF-1 in Growth Hormone-Deficient Children: Is a Second Growth Hormone Stimulation Test Necessary?
Fatani, Tarah H.
JOURNAL OF THE ENDOCRINE SOCIETY, 2023, 7 (04)
[2] Growth Hormone, Not IGF-1 Is the Key Longevity Regulator in Mammals
Brown-Borg, Holly M.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2022, 77 (09): : 1719 - 1723
[3] Comparison of growth hormone stimulation tests in prepubertal children with short stature according to response to growth hormone replacement
Chang, Seong Hwan
Kim, Chan Jong
ANNALS OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2024, 29 (05) : 316 - 324
[4] Combined growth hormone stimulation testing: Could the tests be shortened?
Fatani, Tarah H.
HELIYON, 2023, 9 (08)
[5] Insulin-like growth factor 1 (IGF-1): a growth hormone
Laron, Z
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 2001, 54 (05): : 311 - 316
[6] Craniopharyngioma cell growth is promoted by growth hormone (GH) and is inhibited by tamoxifen: Involvement of growth hormone receptor (GHR) and IGF-1 receptor (IGF-1R)
Li, Qiang
You, Chao
Liu, Liang
Rao, Zhengxi
Sima, Xiutian
Zhou, Liangxue
Xu, Jianguo
JOURNAL OF CLINICAL NEUROSCIENCE, 2013, 20 (01) : 153 - 157
[7] Growth hormone and IGF-1 as doping agents in competitive sport
Jozkow, Pawel
Medras, Marek
ENDOKRYNOLOGIA POLSKA, 2009, 60 (05) : 389 - 394
[8] Evaluation of Safety and Efficacy of Growth Hormone Therapy by IGF-1 Z Score in Children with Short Stature
Liu, Hui-Juan
Wang, Ling-Hong
Chen, Lu
ADVANCES IN THERAPY, 2019, 36 (09) : 2374 - 2383
[9] Doping and sports endocrinology: Growth hormone, IGF-1, insulin, and erythropoietin
Garcia-Arnes, J. A.
Garcia-Casares, N.
REVISTA CLINICA ESPANOLA, 2023, 223 (03): : 181 - 187
[10] An Evaluation of Growth Hormone and IGF-1 Responses in Neonates with Hyperinsulinaemic Hypoglycaemia
Senniappan, Senthil
Hussain, Khalid
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2013, 2013

← 1 2 3 4 5 →